Catalyst Wire Dossier Catalyst Wire Dossier

Edurant

rilpivirine · Janssen Pharmaceuticals
Drug timelines are a Plus or Pro feature.

41 regulatory and trial events tracked for Edurant, covering 2010-04-28 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies [Phase 2]

See pricing